百诚医药 (301096.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(百诚医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) -1.001.001.00--1.001.00-
 单季度销售毛利率(%) 68.0061.0068.0067.0066.0062.0076.0065.0067.00
 单季度销售净利率(%) 23.0023.0028.0032.0022.0026.0034.0044.0020.00
 单季度净资产收益率ROE(%) 2.003.003.003.001.002.003.003.001.00
 单季度总资产净利率ROA(%) 1.002.002.003.001.002.002.002.001.00
单季度财务摘要:
 单季度营业总收入(元) 215,702,842.00303,641,824.00289,944,215.00262,940,990.00160,921,094.00186,667,129.00175,075,260.00149,865,827.0095,802,323.00
 单季度营业总成本(元) 164,553,616.00235,004,460.00192,257,925.00161,339,754.00125,926,754.00160,512,087.00107,298,991.0085,663,553.0080,721,016.00
 单季度营业收入(元) 215,702,842.00303,641,824.00289,944,215.00262,940,990.00160,921,094.00186,667,129.00175,075,260.00149,865,827.0095,802,323.00
 单季度营业利润(元) 47,805,281.0071,302,852.0096,561,674.0096,784,322.0032,372,821.0043,596,594.0064,800,881.0063,386,674.0016,859,281.00
 单季度利润总额(元) 47,897,316.0071,323,256.0096,645,674.0095,346,934.0032,363,626.0036,413,615.0064,803,386.0072,902,713.0016,786,000.00
 单季度净利润(元) 49,818,209.0070,486,065.0082,026,829.0084,392,185.0035,109,633.0048,879,414.0060,209,161.0065,455,973.0019,498,071.00
 单季度归属母公司股东的净利润(元) 49,818,209.0070,478,552.0082,026,829.0084,392,185.0035,068,584.0048,942,238.0060,200,474.0065,491,431.0019,529,828.00
 单季度经营活动产生的现金流量(元) -121,975,609.0056,917,769.0033,358,777.003,544,283.00-3,367,416.00101,764,701.0052,555,616.00138,148,126.00-33,055,022.00
 单季度投资活动产生的现金流量(元) -233,072,878.00-190,202,417.00-194,506,299.00-173,422,178.00-209,284,900.00-223,378,148.00-188,635,423.00-171,357,916.00-107,499,856.00
 单季度筹资活动产生的现金流量(元) 261,247,480.0082,119,280.00-25,986,667.00-58,944,053.00247,293,155.00-5,193,300.00-40,678,979.00-80,191,842.00-240,411,585.00
 单季度现金及现金等价物净增加(元) -93,802,396.00-51,236,605.00-187,136,310.00-228,883,090.0034,640,839.00-126,806,747.00-176,758,786.00-113,401,632.00-380,966,463.00

前瞻产业研究院